This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Article abstract-Myasthenic crisis, defined as respiratory failure requiring mechanical ventilation, occurs in 15 to 20% of patients with myasthenia gravis (MG). Infection (usually pneumonia or viral upper respiratory infection) is the most common precipitant (40%), followed by no obvious cause (30%) and aspiration (10%). As a general rule, 25% of patients are successfully extubated after 1 week, 50% after 2 weeks, and 75% after 1 month. Risk factors for intubation beyond 2 weeks, the point at which tracheostomy is usually performed, include age greater than 50 years, preintubation serum bicarbonate 30 mg/dL or greater, and vital capacity within 6 days of intubation less than 25 mL/kg. Intensive care management of the myasthenic patient should focus on timely intubation, prevention of aspiration with tube feedings, and avoidance of complications, such as atelectasis, that can prolong the duration of crisis. Plasmapheresis leads to short-term improvement of weakness in 75% of patients, and should be performed in all patients unless otherwise contraindicated. Although myasthenic crisis is fatal in approximately 5% of cases, deaths are almost exclusively the result of severe medical comorbidity. Residual weakness leads to functional dependence in 50% of patients at the time of discharge, and one-third will experience two or more episodes of crisis.
NEUROLOGY 1997;48(Suppl 5): S70-S75
- Copyright 1997 by Advanstar Communications Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
